Bisphosphonates (BPs) are an important class of drugs used in the treatment of abnormal calcium metabolism diseases. The first syntheses of bisphosphonates derived from indazole, substituted at the N-1, N-2 and C-3 positions are reported. The 1-hydroxy-1,1-bisphosphonates were synthesized from the corresponding carboxylic acid or acyl chloride compounds, by two different methods. These BPs have a side chain with different lengths ((CH 2 ) n , n = 0-5) between the indazole ring and the bisphosphonate group.
Introduction
Bisphosphonates (BPs) are an important class of drugs known by their broad spectrum of therapeutic applications in the treatment of diseases characterized by abnormal calcium metabolism, such as hypercalcemia, osteoporosis and tumor-associated osteolysis.
1 BPs were first developed as pharmaceuticals in the mid-1960´s and have been used as an effective treatment for Paget's disease. 2 Since then, many BPs were synthesized and made commercially available due to their value in the treatment of disorders of bone mineral. 3 These compounds have high affinity for calcium and therefore to target the bone mineral, where they appear to be internalized selectively by bone-reabsorbing osteoclasts and induce their apoptosis. 4 BPs offer several advantages in treating osteoporosis since they are bone-tissue specific, have minimal side less studied in comparison with other heteroaromatic compounds, such as indole or benzimidazole.
The indazole ring has two nitrogen atoms, like the 3 rd generation BPs, which can lead to an increased effect of BPs and can be functionalized with high selectivity at different positions. The length of the side chain and the different positions at the indazole ring, where it could be bonded, can afford a large number of indazolebisphosphonates, presenting a promising field to achieve new BPs with biological and therapeutical properties.
To the best of our knowledge, no BPs derived from indazole were synthesized. The aim of this work is to obtain new BPs derived from indazole with high potential biological/therapeutical activities.
Here, we report the synthesis and structural characterization of new indazole BPs substituted at different C-or N-positions of indazole rings, and with a side chain with different lengths (CH 2 ) n n=0-5 from the bisphosphonate function to the nitrogen or carbon atom of the ring.
1-Hydroxy-1,1-indazolebisphosphonate derivatives 2a-e were prepared in moderate yield from the corresponding carboxylic acid derived from an indazole substituted at the N-1 position 1a-e (n=1-5), by treatment with a mixture of phosphoric acid and phosphorus trichloride, followed by acid hydrolysis (Table 1) . The separation and purification of BPs were done by precipitation in acetone and methanol, being always a difficult and tedious process, as previously described by other authors. In the case of the compound 2a, with a single methylene group, the yield of the reaction was very low. So, the Lecouvey's alternative method (Method B) was used. The acyl chloride 3a was prepared in situ, by reaction of the carboxylic acid 1a with thionyl chloride, which showed to be very unstable. The acyl chloride 3a reacted with tris(trimethylsilyl)phosphite, followed by methanolysis, to afford BP 2a, in 71% yield (Scheme 1). iii) MeOH
Scheme 1
The 1-hydroxy-1,1-indazole-bisphosphonate derivatives 5a-e were also prepared by reaction of the corresponding carboxylic acid derived from indazole substituted at N-2 position 4a-e (n = 1-5) with phosphorus trichloride and phosphoric acid, followed by acidic hydrolysis (Method A). However, the reactions afforded the BPs in low yields (exception for BP 5e, with n=5) ( Table 2) . In order to increase the yields of these syntheses, the Lecouvey's method (Method B) was used and the synthesis of compound 5b afforded these BP in 77% yield, but compounds 5a and 5c were always isolated in low yields. The lower solubility of compounds 4a and 4c, in the solvent used to prepare the corresponding acyl chloride and the lower stability of the acyl chloride should explain the low yield of BP 5a and BP 5c (Table 2) . 1-Hydroxy-1,1-indazolebisphosphonate 7, prepared from the carboxylic acid 6, substituted at the indazole C-3 position, was synthesized following the method of Lecouvey (Method B) . 21 The reaction of commercially available 1H-indazole-3-carboxylic acid 6 with SOCl 2 , to produce in situ the corresponding acyl chloride, followed by reaction with tris(trimethylsilyl)phosphite and hydrolysis, afforded the BP 7, as white powder, in 67% yield (Scheme 2). 
Scheme 2
To increase the length of the alkyl side chain at the C-3 position, the carboxylic acid derivative 8 was synthesized according to literature procedures, from o-nitrobenzaldehyde, malonic acid and ammonium acetate in acetic acid. 22 
Spectroscopic characterization
Compounds 2a-e, 5a-e, 7 and 9 were fully characterized by NMR (including bidimensional techniques), IR spectroscopy, mass spectrometry (low and high resolution) and elemental analysis.
The BPs were submitted to Electron Impact Ionization (EI) Mass Spectrometry, but most did not show the molecular ion. Fast Atom Bombardment (FAB) or Electrospray Ionization (ESI) methods were used to show the molecular ion of all BPs, which confirmed their proposed molecular formulae. The mass spectra showed characteristic fragment ions corresponding to the loss of H 2 O and H 3 PO 3 fragments.
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The IR spectra of indazolebisphophonates showed the disappearance of the strong C=O stretching band from the carboxylic acid (starting material) and the appearance of two strong characteristic bands at approximately 1250-1100 and 1100-900 cm -1 , due to the ν(P=O) (1200- 11-7.75 ppm, relative to the aromatic ring protons, usually as two one proton doublets (4-H and 7-H) and two one proton triplets (5-H and 6-H), (iv) a singlet (or a doublet, with a very small coupling constant, J 0.6 Hz) at δ 7.99-8.12, which corresponds to the 3-H proton. The 1 H NMR spectra of BPs 5a-e also showed four resonances in the region δ 7.01-7.68
ppm, attributed to the aromatic ring protons, usually as two one proton doublets (4-H and 7-H) and two one proton triplets (5-H and 6-H); these resonances are generally 0.10 ppm upfield from the corresponding signals of the BPs 2a-e. The 3-H proton is observed as one proton singlet or doublet (J 0.6 Hz) at δ 8.30-8.42 ppm, which are generally 0.30 ppm downfield from the signals of the BPs 2a-e. Both BPs 2a and 5a (all with n=1) present the 3-H proton resonance 0.12 ppm downfield relatively to the BPs 2b-e and 5b-e (with aliphatic side chains with more than one methylene group). Compounds 2a and 5a showed a triplet ( 3 J H,P ≈10 Hz), at 4.85 and 4.90 ppm, respectively, due to the coupling of NCH 2 protons with two phosphorous atoms, supporting the proposed structures of two equivalent phosphonate groups attached to the same carbon. The indazoleBPs 7 and 9, derived from indazole substituted at C-3, showed four resonances in the region of δ 7.01-7.28 ppm relative to the aromatic ring protons, as two one proton doublets (4-H and 7-H) and two one proton triplets (5-H and 6-H). The BP 7, which has the 1-hydroxy-1,1-bisphosphonate group bonded to the pyrazole ring of the indazole, with no aliphatic side chain, present the doublet, relative to H-4, 0.5 ppm downfield relative to indazoleBP 9 (with a methylene group at the side chain). The 1 H NMR spectrum of BP 9 has a CH 2 triplet ( 3 J H,P 14
Hz) at δ 3.57 ppm, which confirmed the presence of two equivalent phosphonate groups attached to the same carbon. 13 C NMR spectroscopy also confirms the presence of the bisphosphonate group. The appearance of a quaternary carbon triplet (disappearing in DEPT-135 13 C NMR spectra) at δ 71.1-74.3 ppm (with 2 J C,P 143-146 Hz) supported the proposed structures with two phosphonate groups attached to the same carbon (P-COH-P) ( Tables 3-5) . 13 C NMR is also the best spectroscopic method for assigning the position of substitution, since the C-3, C-7 and C-7a showed different chemical shifts between the N-1, N-2 and C-3 isomers (Table 3 -5) . In N-1 substituted indazoleBPs spectra, C-3 was generally shifted downfield 10 ppm, and C-7 and C-7a were shifted upfield, relatively to the corresponding carbons in N-2 substituted indazoleBPs. The C-3 substituted isomers (BPs 7 and 9) present C-7 and C-7a with similar chemical shifts to the N-1 isomers but the C-3 quaternary carbon atom was observed further downfield, at approximately 8 ppm. The assignment of the C-3 isomers was supported by HSQC and HMBC spectra ( Table 5 ). The connectivities found in these spectra allowed the full assignment of proton and carbon atoms, including the three quaternary carbon resonances. We may note that C-3 and C-7a have similar chemical shifts, but C-3, relative to C-7a, is observed upfield in BP 7 and downfield in BP 9.
The proton-decoupled 31 P NMR spectra of indazoleBPs 2, 5, 7 and 9 showed a single signal in the range of 15.4-21.1 ppm, which confirmed that two phosphorus atoms are magnetically equivalent. The chemical shifts of phosphorus atoms are similar between the corresponding isomers. The lower chemical shift is observed for indazoleBP 7, with no aliphatic side chain, with the phosphorus atoms connected to a carbon atom directly bonded to the aromatic indazole ring. The chemical shift generally increases with the increasing number of methylene groups in side chain. Table 4 . 13 C NMR data of compound N-2 isomers 5a-e in DMSO-d 6 13 C NMR, δ BP n Ar:C-7 Ar:C-5 Ar:C-4 Ar:C-6 Ar:C-3 Ar:C-3a Ar:C-7a 
Conclusions
We report the first synthesis of 1-hydroxy-1,1-indazolebisphosphonates substituted at N-1, N-2 and C-3 positions of indazole ring, with the side chain with different (CH 2 ) n groups (n=1-5 for N-1 and N-2 isomers and n=0,1 for C-3 BPs), in moderated to good yields, starting from their corresponding carboxylic acids or acyl chlorides. In order to increase the synthetic yields, two different methods were used. Despite the difficulty in the separation and purification of these bisphosphonates, they were fully characterized using the usual spectroscopic methods, especially NMR spectroscopy, including two dimensional NMR techniques. NMR spectroscopic characterization allowed the assignment of 1 H-and 13 C-atoms of different BPs. The presence of a quaternary carbon triplet confirmed the presence of the bisphosphonate group with two equivalent phosphorous atoms bonded to the same carbon atom. This work also showed that NMR spectroscopy allowed the easy identification of the N-1, N-2 and C-3 isomers since they showed spectra with different chemical shifts, especially the C-3, C-7 and C-7a 13 C NMR signals. The N-1 indazole BPs showed C-3 carbon atom generally shifted downfield (≈10 ppm) relative to the corresponding carbon atom in N-2 indazole BPs, while C-7 and C-7a were shifted upfield. The C-7 and C-7a carbon atoms of C-3 substituted BPs (BPs 7 and 9) have similar chemical shifts relative to N-1 isomers but the C-3 quaternary carbon atom was observed further downfield, at approximately 8 ppm. Connectivities in HMBC spectra of BPs 7 and 9 also showed that those compounds present inversion in the chemical shift of C-3 and C-7a quaternary carbon atoms. These synthesized BPs will be submitted to in vitro and in vivo studies to assess their potential therapeutic applications (studies currently in progress). from indazole substituted at C-3 were synthesized in a two step synthesis according to reported synthetic procedures.
Experimental Section
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General procedure 1 (Method A)
A mixture of a carboxylic acid (1 eq.), H 3 PO 4 (85%) (2 eq.) and chlorobenzene was heated to 100-110 °C with stirring. After all solids were dissolved, PCl 3 (3 eq.) was added slowly and the reaction mixture was vigorously stirred at 100-110 °C for 5 h. After cooling, chlorobenzene was decanted and 9 N HCl was added to the residue. The resulting solution was refluxed for 3 h and the solvent was removed under reduced pressure. Acetone and methanol were added to precipitate the 1-hydroxy-1,1-indazolebisphosphonate as a white powder, which was washed with acetone and dried.
General procedure 2 (Method B)
A mixture of a carboxylic acid (1 eq.) in CHCl 3 and thionyl chloride (4 eq.) was kept under reflux for 2 h. Solvents were removed under reduced pressure to give the corresponding acyl chloride, which was immediately used without further purification. The crude acyl chloride was dissolved in dry THF and tris(trimethylsilyl)phosphite (2 eq.) was added. Then, the mixture was stirred at room temperature for 30 min. The excess solvent was removed under reduced pressure and methanol was added and the mixture was stirred for 1 h. After solvent removal under reduced pressure, the residue was washed with ethyl ether and precipitated with acetone. , 3428, 3152, 3120, 3014, 2972, 2794, 1629, 1519, 1464, 1433, 1412, 1383, 1322, 1191, 1158, 1136, 1106, 1076, 1007, 963, 900, 863, 766, 758, 659, 608, 563, 540, 455 Hydroxy-3-(1H-indazol-1-yl) propane-1,1-diyl]bis(phosphonic acid) (2b). Following general procedure 1 (Method A), BP 2b was isolated as a white powder (60%), mp 127-130 ºC. υ max (KBr) (cm -1 ): 3534, 3494, 3417, 3129, 3044, 2953, 2922, 2782, 1645, 1616, 1504, 1465, 1431, 1380, 1368, 1323, 1278, 1246, 1231, 1194, 1172, 1151, 1073, 1018, 941, 920, 899, 875, 849, 765, 754, 665, 635, 608, 567, 546, 534, 479, 456 [1-Hydroxy-4-(1H-indazol-1-yl)butane-1,1-diyl]bis(phosphonic acid) (2c) . Following general procedure 1 (Method A), BP 2c was isolated as a white powder (44%), mp 103-104 ºC. υ max (KBr) (cm -1 ): 3400, 3121, 2946, 1636, 1459, 1414, 1390, 1333, 1192, 1144, 1114, 1078, 1001, 951, 861, 846, 765, 670, 656, 590, 563, 540, 516, 485, 435 [1-Hydroxy-5-(1H-indazol-1-yl)pentane-1,1-diyl]bis(phosphonic acid) (2d). Following general procedure 1 (Method A), the BP 2d was isolated as a white powder (62%), mp 128-130 ºC. υ max (KBr): 3291, 3138, 2967, 2924, 2855, 2759, 1634, 1522, 1466, 1385, 1323, 1262, 1190, 1162, 1142, 1084, 1053, 1004, 965, 891, 759, 669, 530, 469, 430cm H 2 ) 2 ), 110.5 (Ar:C-7), 121.9, 122.2 (Ar:C-4,C-5), 127.9 (Ar:C-6), 133.7 (Ar:C-3), 125.1 (Ar:C-3a), 140.7 (Ar:C-7a Hydroxy-6-(1H-indazol-1-yl)hexane-1,1-diyl]bis(phosphonic acid) (2e) . Following general procedure 1 (Method A), BP 2e was isolated as a white powder (50%). mp 118-120 ºC. υ max (KBr) 3377, 3128, 2942, 2866, 1631, 1466, 1384, 1367, 1171, 1139, 1092, 1007, 947, 838, 754, 670, 662, 514 cm -1 . 1 H NMR (300 MHz, MeOD-d 4 ): δ (ppm) = 1.28 (2H, m, CH 2 ), 1.73 (2H, m, CH 2 ), 1.90 (4H, m, CH 2 ), 4.42 (2H, t, J 6.9, NCH 2 CH 2 ), 7.14 (1H, t, J 7.8, ArH, 7.41 (1H, m, ArH, 7.57 (1H, d, J 8.4, ArH, 7.74 (1H, d, J 8.4, ArH, 8.01 (1H, s, . 13 [1-Hydroxy-2-(2H-indazol-2-yl)ethane-1,1-diyl]bis(phosphonic acid) (5a). Using general procedure 1 (Method A), compound 5a was isolated as a white powder (6%), mp 181ºC (decomp.), υ max (KBr) 3445, 2922, 2856, 1645, 1456, 1199, 1140, 1078, 1011, 945, 853, 752cm (KBr): 3432, 3294, 3109, 2894 (KBr): 3432, 3294, 3109, , 2618 (KBr): 3432, 3294, 3109, , 2553 (KBr): 3432, 3294, 3109, , 1639 (KBr): 3432, 3294, 3109, , 1528 (KBr): 3432, 3294, 3109, , 1432 (KBr): 3432, 3294, 3109, , 1390 (KBr): 3432, 3294, 3109, , 1370 (KBr): 3432, 3294, 3109, , 1246 (KBr): 3432, 3294, 3109, , 1217 (KBr): 3432, 3294, 3109, , 1168 (KBr): 3432, 3294, 3109, , 1149 (KBr): 3432, 3294, 3109, , 1133 (KBr): 3432, 3294, 3109, , 1054 (KBr): 3432, 3294, 3109, , 1013 22 (1H, t, J 8.4, ArH, 7.58 (1H, d, J 8.7, ArH, 7.68 (1H, d, J 8.4, ArH, 8.30 (1H, s, . 13 O requires C, 32.27, H, 4.87, N, 7 .53%.
[1-Hydroxy-4-(2H-indazol-2-yl)butane-1,1-diyl]bis(phosphonic acid) (5c). Following general procedure 1 (Method A) and the general procedure 2 (Method B), 5c was isolated as a white powder (17%), mp 174-175 ºC. υ max (KBr) (cm -1 ): 3421, 3220, 3132, 2958, 2928, 2781, 1637, 1529, 1388, 1369, 1216, 1185, 1162, 1003, 990, 945, 760, 670, 648, 633, 613, 525, 510, 467 [1-Hydroxy-5-(2H-indazol-2-yl)pentane-1,1-diyl]bis(phosphonic acid) (5d). Following general procedure 1 (Method A), BP 5d was isolated as a white powder (39%). mp 202-203 ºC. υ max (KBr) (cm -1 ): 3398, 3199, 3016, 2958, 2853, 2685, 1638, 1528, 1388, 1364, 1241, 1172, 1148, 1127, 1108, 1088, 1030, 996, 973, 930, 900, 828, 757, 744, 638, 610, 530, 520, 488, 478, 468, 449 Hydroxy-6-(2H-indazol-2-yl)hexane-1,1-diyl]bis(phosphonic acid) (5e) . Following general procedure 1 (Method A), BP 5e was isolated as a white powder (87%), mp 144-145 ºC. υ max (KBr) (cm -1 ): 3367, 3126, 3108, 2929, 2861, 2764, 2695, 1637, 1528, 1466, 1458, 1388, 1367, 1165, 1146, 1062, 1002, 939, 757, 668, 662, 612, 569 3555, 3408, 3257, 3061, 2998, 2940, 2766, 2701, 1636, 1560, 1522, 1456, 1399, 1358, 1241, 1170, 1086, 1020, 954, 918, 894, 882, 807, 767, 747, 663, 586, 525, 487, 445 2 O requires: C, 27.92, H, 4.10, N, 8.14% . [1-Hydroxy-2-(1H-indazol-3-yl)ethane-1,1-diyl]bis(phosphonic acid) (9) . Using the general procedure 2, Method B, BP 9 was isolated as a white powder (16%), mp 200-202 ºC (decomp.). υ max (KBr) (cm -1 ): 3448, 3204, 2997, 2926, 2864, 2744, 1638, 1420, 1388, 1358, 1220, 1154, 1142, 1082, 1061, 1008, 925, 897, 843, 779, 757, 698, 536, 504, 468 
